Drug Discovery & Trials

Targets, biomarkers, AI discovery, and Phases I–III clinical results.

  • 19 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Drug Discovery & Trials


centerforahumaneeconomy.org > fda-takes-crucial-step-to-accelerate-alternatives-to-animal-testing

Breaking: FDA Takes Crucial Step To Accelerate Use Of Alternatives To Animal Testing

24+ min ago   (787+ words) Today is one of the most impactful days ever in our quest to reduce animal testing in drug development and to replace an old, tired, broken system that relied on tormenting dogs, primates, and other animals with 21st-century methods grounded…...


inquisitiveminds.bristows.com > post > 102o1p2 > a-new-spin-on-spinouts-cambridges-model-for-medtech-innovation

A new spin on spinouts? Cambridge’s model for medtech innovation (via Passle)

6+ hour, 47+ min ago   (305+ words) An overview of the OSA, covering its scope, key obligations and what organisations need to navigate the evolving regulatory landscape. We advise companies in the women's health sector on the commercial, legal and regulatory challenges of bringing new therapies and…...


ptinews.com > press-release > bioshanghai-week-2026-opens----joining-forces-to-build-a-global-biopharmaceutical-innovation-ecosystem > 4085165

BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem

9+ hour, 52+ min ago   (14+ words) ptinews.com...


eagletribune.com > region > serbisches-biotech-start-up-begibt-sich-mit-einer-dokumentation-ber-langlebigkeitsforschung-auf-eine-reise-von > article_84cc710a-f70f-5e78-9b77-231e69c6ab9a.html

Serbisches Biotech-Start-up begibt sich mit einer Dokumentation über Langlebigkeitsforschung auf eine Reise von Belgrad nach Cambridge

2+ hour, 48+ min ago   (177+ words) Eagle-Tribune Serbisches Biotech-Start-up begibt sich mit einer Dokumentation über Langlebigkeitsforschung auf eine Reise von Belgrad nach Cambridge Cambridge Tech Week 2026 BELGRAD, Serbien--(BUSINESS WIRE)--Sep 21, 2026-- BioEridan, ein serbisches Biotechnologie-Start-up, das vom TS Ventures Fund der Telekom Srbija Group unterstützt wird,…...


indianpharmapost.com > news > sartorius-and-nibrt-to-launch-global-continuous-bioprocessing-training-hub-in-dublin-21930

Sartorius and NIBRT to launch global continuous bioprocessing training hub in Dublin

11+ hour, 17+ min ago   (52+ words) Puresta's EVERQ brings AI-led skin assessment and dermatologist care into one platform Alma Lasers launches Accent Prime in Gurugram Neurizon’s ALS therapy to be made available to 200 patients India to roll out digital drug regulatory system soon: DCGI Priyaranjan Jha…...


joplinglobe.com > region > national_business > servische-biotech-start-up-brengt-zijn-activiteit-van-belgrado-naar-cambridge-met-een-documentaire-over > article_cffc1d95-cad5-5f7b-b0a7-faff85853e8d.html

Servische biotech start-up brengt zijn activiteit van Belgrado naar Cambridge met een documentaire over longevity-wetenschap

2+ hour, 58+ min ago   (160+ words) The Joplin Globe - Download the Globe app to my phone or tablet Servische biotech start-up brengt zijn activiteit van Belgrado naar Cambridge met een documentaire over longevity-wetenschap Cambridge Tech Week 2026 BELGRADO, Servië--(BUSINESS WIRE)--sep 21, 2026-- BioEridan, een Servische biotechnologiestart-up gesteund…...


allsci.com > news > licensing-and-partnerships > ai-drug-discovery-platform-hanx

Hanx Bio licenses XtalPi AI drug discovery platform for biologics R&D

6+ hour, 37+ min ago   (363+ words) AllSci Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKEX: 03378) and XtalPi Holdings Limited (HKEX: 02228) have entered into a Strategic Cooperation Framework Agreement and a platform use license agreement granting Hanx access to XtalPi's AI-driven drug discovery platform, XtalPi Science, to support its…...


note.com > noka_analytics > n > n49cc827f5e1d

Adaptive Biotechnologies | Science & Technology｜NOCA

1+ day, 14+ hour ago   (214+ words) Carlson, C.S. et al. (2022) ‘Using Synthetic Templates to Design an Unbiased Multiplex PCR Assay’, Nature Communications. Ching, T. et al. (2020) ‘Analytical Evaluation of the clonoSEQ Assay for Establishing Measurable (Minimal) Residual Disease in Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, and Multiple…...


eu.36kr.com > en > p > 3992900668856199

ByteDance, Baidu, Hengrui & Novo Nordisk: Driving Breakthroughs in AI Pharmaceutical Commercialization

7+ hour, 19+ min ago   (1446+ words) Leading pharmaceutical giants and top internet companies are all scrambling to make layouts in AI drug R&D. Multinational pharmaceutical firm Novo Nordisk officially announced its partnership with Anthropic to carry out in-depth R&D cooperation on the Claude Science large…...


via.ritzau.dk > pressemeddelelse > 15/17/4832 > brendan-bioanalytics

Brendan Bioanalytics | Globenewswire

9+ hour, 21+ min ago   (367+ words) STATLIA MATRIX MP Sets New Standard for Multiplex Assay Analysis and QC Automation CARLSBAD, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Brendan Bioanalytics has released STATLIA MATRIX MP, a powerful data analysis enterprise software system designed to improve the accuracy, reliability, and efficiency…...